ASCLEPIX THERAPEUTICS, INC.

Profile

Company Names

ASCLEPIX THERAPEUTICS, INC.
ASCLEPIX THERAPEUTICS, LLC

Addresses

5237 RIVER ROAD, #334, BETHESDA, MD 20816

301 WEST 29TH STREET, SUITE 2004, BALTIMORE, MD 21211

810 WYMAN PARK DRIVE, BALTIMORE, MD 21211

Phone Numbers

610-212-1217
410-657-2627

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

MARYLAND

Total Amount Raised:

$27,954,998.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-07-19 
$10,044,498.00 
$12,544,498.00 
$2,500,000.00 
Equity 
3
2020-05-27 
$10,000,000.00 
$35,000,000.00 
$25,000,000.00 
Equity 
2
2018-10-12 
$7,735,500.00 
$10,000,000.00 
$2,264,500.00 
Debt 
1
2017-02-03 
$175,000.00 
$1,000,000.00 
$825,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
 
ALTSCHULER 
DIRECTOR
WEIGHT WATCHERS INTERNATIONAL INC   |  IMVAX, INC.   |  AFFINIVAX, INC.   |  ORCHARD THERAPEUTICS PLC   |  PLATELET BIOGENESIS, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  CORNER THERAPEUTICS, INC.
STEVEN 
 
ALTSCHULER, MD 
DIRECTOR
ASCLEPIX THERAPEUTICS, INC.
BEN 
 
ASKEW 
DIRECTOR
A-ALPHA BIO, INC.   |  SURF BIO, INC.   |  ASCLEPIX THERAPEUTICS, INC.
JOSH 
 
BARER 
DIRECTOR
ASCLEPIX THERAPEUTICS, INC.
JOSHUA 
 
BARER 
DIRECTOR
ASCLEPIX THERAPEUTICS, INC.   |  SENDERO BIOTECHNOLOGY, INC.   |  HIBISCUS CAPITAL MANAGEMENT FUND II LP
ROBERT 
 
DEMPSEY 
EXECUTIVE OFFICER
TEARCLEAR CORP.   |  SCIFLUOR LIFE SCIENCES, INC.   |  OCUTERRA THERAPEUTICS, INC.   |  ASCLEPIX THERAPEUTICS, INC.
CHRIS 
 
GARABEDIAN 
DIRECTOR
QUELLIS BIOSCIENCES, INC.   |  VYOME THERAPEUTICS INC.   |  CEREVASC, INC.   |  NEPHRODI THERAPEUTICS, INC.   |  FORGE BIOLOGICS HOLDINGS, LLC   |  SHIFA BIOMEDICAL CORP   |  JUNO DIAGNOSTICS, INC.   |  TELLUS THERAPEUTICS, INC.   |  STREAM BIOMEDICAL, INC.   |  POLYCORE THERAPEUTICS, INC.   |  VIVOSENSE, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  MAREA THERAPEUTICS, INC.   |  ZUCARA THERAPEUTICS INC.
JORDAN 
 
GREEN 
DIRECTOR
ASCLEPIX THERAPEUTICS, INC.
JORDAN 
J. 
GREEN 
DIRECTOR, EXECUTIVE OFFICER
ASCLEPIX THERAPEUTICS, LLC   |  ASCLEPIX THERAPEUTICS, INC.   |  DOME THERAPEUTICS, LLC
NIRANJAN 
 
PANDEY 
EXECUTIVE OFFICER
ASCLEPIX THERAPEUTICS, INC.
WENDY 
 
PERROW 
EXECUTIVE OFFICER, DIRECTOR
ASCLEPIX THERAPEUTICS, LLC   |  ASCLEPIX THERAPEUTICS, INC.
ALEKSANDER 
 
POPEL 
EXECUTIVE OFFICER
ASCLEPIX THERAPEUTICS, INC.
ALEKSANDER 
 
POPEL, PHD 
DIRECTOR
ASCLEPIX THERAPEUTICS, INC.
ALEKSANDER 
S. 
POPEL, PHD 
DIRECTOR, EXECUTIVE OFFICER
ASCLEPIX THERAPEUTICS, LLC   |  ASCLEPIX THERAPEUTICS, INC.
AMIR 
 
SHOJAEI 
EXECUTIVE OFFICER
THEROPTIX, INC.   |  ASCLEPIX THERAPEUTICS, INC.   |  TEARSOLUTIONS, INC.
KEVIN 
 
SLAWIN, MD 
DIRECTOR, EXECUTIVE OFFICER
ASCLEPIX THERAPEUTICS, INC.
SAPNA 
 
SRIVASTAVA 
DIRECTOR
MYOS CORP   |  ASCLEPIX THERAPEUTICS, INC.   |  EGENESIS, INC.   |  ALUMIS INC.
JILL 
 
TIERNEY 
EXECUTIVE OFFICER
ASCLEPIX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-19 
2020-06-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-27 
2019-06-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-10-12 
2018-10-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-10-12 
2017-02-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SOLEBURY CAPITAL LLC
143299